NutritionFacts.org is a non-profit, strictly non-commercial, science-based public service organization that provides free updates on the latest in nutrition research
People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid GLP-1 medications
This dual-action medication not only supports weight loss but also contributes to better blood sugar control, making it a valuable option for many individuals
Communication with the prescribing clinician is essential before making any dose adjustments, as this may affect glycemic control or weight management outcomes
Many patients notice a temporary rush, warming sensation, or flushing feeling shortly after the injection
Cardiovascular Benefits : Studies have shown that semaglutide can reduce the risk of heart attack, stroke, and other cardiovascular problems in people with type 2 diabetes